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Abstract  37 
Background: Psychosis is characterized by problems in social functioning that exist well before 38 illness onset, and in individuals at clinical high-risk (CHR) for psychosis. Trust is an essential 39 element for social interactions that is impaired in psychosis. In the trust game, chronic patients 40 showed reduced baseline trust, impaired response to positive social feedback, and attenuated brain 41 activation in reward and mentalizing areas. We investigated whether first episode psychosis 42 patients (FEP) and CHR show similar abnormalities in the neural and behavioral mechanisms 43 underlying trust. 44 Methods: Twenty-two  FEP, 17 CHR, and 43 healthy controls performed two trust games, with a 45 cooperative and an unfair partner in the fMRI scanner. Region of interest analyses were performed 46 on mentalizing and reward processing areas, during the investment and outcome phases of the 47 games. 48 Results: Compared to healthy controls, FEP and CHR showed reduced baseline trust, but like 49 controls, learned to trust in response to cooperative and unfair feedback. Symptom severity was not 50 associated with baseline trust, however in FEP associated with reduced response to feedback. The 51 only group differences in brain activation were that CHR recruited the temporo-parietal junction 52 (TPJ) more than FEP and controls during investment in the unfair condition. This hyper-activation 53 in CHR was associated with greater symptom severity. 54 Conclusions: Reduced baseline trust may be associated with risk for psychotic illness, or generally 55 with poor mental health. Feedback learning is still intact in CHR and FEP, as opposed to chronic 56 patients. CHR however show distinct neural activation patterns of hyper-activation of the TPJ.  57 Keywords: 58 
First episode psychosis; clinical high-risk; trust; social feedback; fMRI  59 




1 Introduction 60 
Psychosis is characterized by problems in social functioning (Couture et al, 2006; Fett et al, 2012). 61 Lower social functioning is already present in childhood in individuals who continue to develop 62 psychosis and has also been reported in individuals at high-risk for psychosis (Ballon et al, 2007; 63 Corcoran et al, 2011; Cornblatt et al, 2007; Velthorst et al, 2016a; Velthorst et al, 2016b; Yung et al, 64 2003). Clinical high-risk patients (CHR) are already in care for other psychopathology, reporting 65 psychotic-like symptoms, but have not yet experienced – and maybe never will –full-blown 66 psychosis. In CHR, the developmental course of social functioning is predictive of the conversion to 67 psychosis (Cannon et al, 2008; Jang et al, 2011; Niendam et al, 2007). Understanding the 68 mechanisms underlying deficits in social functioning in at-risk states and first-episode psychosis 69 (FEP) is crucial for understanding transition and outcome prognosis. Intervening at these early 70 stages targeting social functioning can improve outcome and possibly delay (or prevent) transition. 71 
Social functioning relates to establishing relationships, both vocational and private 72 (Velthorst et al, 2016a; Velthorst et al, 2016b). Patients show a steep decline in these domains 73 starting about five years before illness onset. The basis of social functioning is the ability to interact 74 in an appropriate way with other people. Previous research studying online social interactions in 75 psychosis has suggested two possible explanatory mechanisms for impairments in social 76 interactions; these are a reduced sensitivity to rewarding effects of social contact (Campellone et al, 77 2016; Fett et al, 2012; Gromann et al, 2013), and an impaired social cognitive ability (Csukly et al, 78 2011; Horat et al, 2017), including impaired mentalizing (Green et al, 2015). Social cognitive skills 79 (Couture et al, 2006; Green & Leitman, 2008) are necessary for the formation and maintenance of 80 relationships and for building trust in other people. Like patients with psychosis, CHR show deficits 81 in a variety of these skills (Bora & Pantelis, 2013; Lavoie et al, 2013; McCleery et al, 2014), albeit to 82 a lesser degree. Research has mainly focused on off-line cognitive skills, without investigating them 83 




in real interactions. In the last decade, interactive designs have been widely used, that have the 84 strength to capture social cognitive skills, as well as the rewarding effects of social behavior in an 85 on-line setting. We therefore investigated cooperative and unfair social interactions and the neural 86 correlates of trust, directly comparing FEP and CHR to controls, using an interactive trust game to 87 test whether these groups display similar underlying mechanisms of reduced social interactions. 88 
The trust game investigates real-time social interactions (Berg et al, 1995). In the game, the 89 first player (investor), receives a certain endowment, e.g.,  €10. He or she can give any amount 90 between €0 and €10 to the second player, the trustee. The given amount is tripled and the trustee 91 then can return any part of this amount to the investor. The best pay-off for the trustee is reached 92 by keeping the money. Thus, investing requires trust that a fair repayment will be made. The 93 iterative game allows for the investigation of baseline trust (i. e. first investment), and the 94 development of trust based on cooperative and unfair social feedback. Key-processes involved in 95 the trust game are thought to be mentalizing (Declerck et al, 2013; Frith & Frith, 2006; Gallagher & 96 Frith, 2003) and reward processing (Fehr & Camerer, 2007; King-Casas et al, 2005; Rilling & Sanfey, 97 2011). Mentalizing appears to be important during both the investment and repayment phase, 98 where estimations of the other’s behavior are made. Reward learning signals have been shown to 99 shift from the repayment phase to the investment phase in an iterative trust game (King-Casas et al, 100 2005). Hence, we investigated both the investment and repayment phase (Figure 1). 101 
Research in healthy subjects has shown that participants initially invest more than half of 102 their endowment (Berg et al, 1995; Johnson & Mislin, 2011). Studies from our lab have shown that 103 baseline trust tends to be lower in patients than controls (Fett et al, 2016; Gromann et al, 2013). 104 Both positive (Fett et al, 2012) and negative (Fett et al, 2016) symptoms have been associated with 105 lower baseline trust, suggesting that reduced trust may reflect either paranoia or a lack of social 106 motivation. The ability to learn from social feedback seems to depend on context (cooperative or 107 




unfair partner’s responses) and illness duration: Early psychosis patients were able to adjust their 108 trust to similar levels as controls, whereas chronic patients showed an insensitivity to positive 109 feedback. In unfair interactions, early and chronic psychosis patients responded adequately to 110 negative feedback (Campellone et al, 2016; Fett et al, 2015; Fett et al, 2016; Fett et al, 2012; 111 Gromann et al, 2013). Understanding the mechanisms of trust in early psychosis stages may 112 provide insights in focal points to target in social functioning interventions. 113 
At the neural level, reduced caudate activation in chronic patients has been reported in 114 cooperative interactions. Relatives of patients with psychosis, despite behavioral outcomes similar 115 to controls, also showed reduced recruitment of the caudate and insula. These results possibly 116 reflect reduced sensitivity to social reward processing mechanisms in both patients and relatives 117 (Gromann et al, 2013; Gromann et al, 2014), which could account for social impairments. 118 Associations of neural activity with positive symptoms have been reported (Gromann et al, 2013).  119 
This study set out to investigate whether CHR and FEP patients, similar to chronic patients, 120 show reduced baseline trust and to explore the neural mechanisms underlying trust behavior in 121 these patient groups. Based on the existing trust game literature, we hypothesized that similar to 122 relatives (Fett et al, 2012) and (chronic) patients (Fett et al, 2015) 1) FEP and CHR will show lower 123 levels of baseline trust, and 2) CHR and FEP are able to learn from positive and negative feedback 124 given by the counterpart and adjust their levels of trust accordingly (Fett et al, 2015; Gromann et al, 125 2013). In both cases, we expected CHR to perform in between FEP and controls. In addition, the 126 associations of symptoms with baseline trust and changes in trust in FEP and CHR were examined. 127 On the neural level we hypothesized to find 3) attenuated activation in brain areas associated with 128 mentalizing and reward (learning) in FEP compared to controls. Based on the trust literature in 129 relatives and imaging research in CHR (Smieskova et al, 2013), we expected intermediate activation 130 in CHR. Based on the findings by Gromann et al (2013), we hypothesized to find 4) positive 131 




symptoms related positively to brain activation in mentalizing and negatively to reward areas in 132 both patient groups. In addition, associations of brain activations with negative symptoms were 133 investigated. 134 
 135 
2 Methods 136 
2.1 Subjects 137 
Twenty-six FEP patients with non-affective psychosis, aged 16-22, and 17 CHR, aged 16-31, were 138 recruited in the Amsterdam and The Hague area. Forty-nine healthy control participants (aged 16-139 31) were recruited to match both patient populations on age and gender. Patients were contacted 140 through their caregivers at the academic medical center Amsterdam (AMC), the Amsterdam early 141 intervention team psychosis and PsyQ, The Hague. FEP were diagnosed at the AMC, according to the 142 DSM-IV criteria (Association & Association, 2000). FEP were included within 18 months of the 143 diagnosis (mean 5.6 months). CHR were help seeking individuals that were referred to PsyQ by 144 their general practitioners or other mental health institutions. After an initial diagnosis based on 145 their complaints, all new admissions (between age 14-35) were screened for an “at-risk mental 146 state” (ARMS) with the Comprehensive Assessment of At-Risk Mental States (CAARMS) (Yung et al, 147 2005), a semi-structured interview that assesses psychotic experiences in the last year before 148 assessment. Only the positive symptoms sub-scale was used, and both intensity and frequency of 149 the symptoms were assessed. Patients met ARMS criteria for attenuated psychotic symptoms (a) 150 with subthreshold intensity, when scoring 3-5 on severity and 3-6 on frequency of symptoms (all 151 CHR participants), (b) or based on subthreshold frequency, when scoring 5-6 on severity and 3 or 152 above on frequency (N = 2, in combination with intensity), or based on vulnerability, i.e., 153 schizotypal personality disorder, familial history of psychosis, or a drop in social functioning (N = 3, 154 




in combination with intensity) (for details, see (Yung et al, 2005), p. 966). Patients were diagnosed 155 as having a full-blown psychosis when scoring higher than 6. Additionally, patients had to display 156 marked problems in socially useful activities (work and study), relationships, and self-care, 157 indicated by a score below 55 on the Social and Occupational Functioning Assessment Scale 158 (SOFAS; mean score 46.9) (Goldman et al, 1992; Morosini et al, 2000), see also  (Rietdijk et al, 159 2012). CHR were included within one year after CAARMS assessment (mean 4.8 months). Fourteen 160 CHR patients also took part in a larger study (EU-GEI), with post-measurements at 6, 12 and 24 161 months using the CAARMS. Of two CHR participants, follow-up data are missing. Symptoms of 162 depression and anxiety are often the primary presenting complaints of CHR patients, rather than 163 the attenuated psychotic symptoms (Modinos et al, 2014). Similar to other CHR samples (Fusar-Poli 164 et al, 2014; Kelleher et al, 2012; Morrison et al, 2012; Wigman et al, 2012; Woods et al, 2009), the 165 current CHR sample had comorbid diagnoses of anxiety (5), personality (3), eating (2) and mood 166 (2) disorders, trauma (2), and ADHD (3). Exclusion criteria for all participants were an IQ < 80 and 167 contraindications for scanning. For FEP additional exclusion criteria were a primary diagnosis of a 168 mood disorder, and comorbidity with autism spectrum disorder. Healthy control participants were 169 excluded if they had a (family) history of psychopathology, which was assessed with self-report, 170 and by a systematic interview with questions regarding past and present mental help seeking, 171 depressed and psychotic symptoms, and intake of medication. 172 We excluded four FEP and six controls due to invalid behavioral data (1 FEP and 2 controls), 173 unusable or missing imaging data (3 FEP and 4 controls). The analysis sample consisted of 22 FEP, 174 17 CHR and 43 controls.  175 
2.2 Measures  176 
2.2.1 Trust game 177 




Participants played the role of investor in two multi-round trust games. They were told that they 178 were connected to their anonymous counterpart via the Internet. In reality, they played against a 179 computer, programmed to respond either in a cooperative or in an unfair way. In the cooperative 180 condition, the return was 100%, 150% or 200% of the invested amount, with increasing likelihood 181 of a 200% repayment after each increase of investment. In the unfair condition the return was 75% 182 or 50%, with increasing likelihood of a 50% repayment after increase of investment. The two 183 games were presented in counterbalanced order. Each game consisted of 20 experimental and 20 184 control trials (Figure 1). For a detailed description of the paradigm see Lemmers-Jansen et al 185 (2017). After the trust game, a questionnaire to investigate participants’ opinions on the behavior 186 of their counterpart was administered, to check if participants believed that they were playing a 187 real person.  188 
2.2.2 Positive and Negative Syndrome Scale (PANSS; Kay et al, 1987) 189 
The 30-item PANSS semi-structured interview was used for rating symptoms in the two weeks 190 prior to testing. The PANSS distinguishes between positive, negative, and general symptoms (Kay et 191 al, 1987). Items are scaled on a 7-point Likert scale, ratings 3 and higher indicating clinical values. 192 All FEP and 13 CHR completed the interview. Interviews were taken by four researchers, and audio 193 tapes (and if consented video tapes) were made. Responses were rated on the basis of the 194 recordings and notes taken during the interview, by two researchers. Based on the first participants 195 an interrater reliability was calculated (r = .85). All PANSS data were rated by the same two 196 researchers. 197 
2.2.3 Wechsler Adult Intelligence Scale (WAIS; Wechsler, 1997) 198 
To control for confounding effects of intelligence, the vocabulary subscale of the WAIS was 199 included, a measure of verbal comprehension, consisting of 33 words that had to be defined by the 200 




participants. Answers were coded as fully correct (2 points), partially correct (1) or wrong (0), 201 resulting in a maximum score of 66. 202 
2.2.4 Trust Manipulation Check Questionnaire 203 
The trust game was followed by a questionnaire to investigate participants’ opinions on the 204 behavior of their counterpart, and to check if they believed that they were playing a real person 205 (“What do you think this task was about?”, “What were the main causes that influenced your 206 behavior during the task?”, “Did you use a strategy during the tasks? If so, which strategy?”, and 207 “Did you think that the counterparts made fair choices?”). The last questions required answers 208 specified per counterpart. If a participant referred to the two counterparts as persons in his/her 209 responses, we regarded the manipulation as successful. If participants reported on any of the 210 questions that they had doubts, or did not believe that the counterpart was real, the manipulation 211 was coded as failed. Four controls, three FEP and one CHR did not believe the manipulation.  212  213 
2.3 Procedure 214 
This research was approved by the Medical Ethical Committee of the VU Medical Center 215 Amsterdam. All participants signed an informed consent, and completed several questionnaires 216 that are not included in the current paper. We then administered the PANSS to FEP and CHR 217 patients. Prior to scanning, participants received oral and written instructions for the trust game, 218 illustrated with screenshots of the game to illustrate the task. Participants played several practice 219 rounds on a computer, accompanied by additional feedback, to ensure understanding of the task. 220 Subsequently participants were scanned for about an hour. First, participants performed the trust 221 game, followed by the structural scan. After this period of relative rest, they performed a second 222 task (the Social Mindfulness Paradigm, to be reported in a separate paper (in preparation)), 223 




followed by a resting state scan. Immediately after scanning, a manipulation check for the trust 224 game was administered (see 2.2.4). Participants received an image of their brain, 25€ for 225 participation and reimbursement of their travel costs.  226 
2.4 fMRI Data Acquisition.  227 Imaging data were obtained at the Spinoza Center Amsterdam, using a 3.0 T Philips Achieva whole 228 body scanner (Philips Healthcare, Best, The Netherlands) equipped with a 32 channel head coil. A 229 T2* EPI sequence (TR = 2.31, TE = 27.63, FA = 76.1º, FOV 240mm, voxel size 2.5 x 2.5 x 2.5, 40 230 slices, 0.3 mm gap) was used, which resulted in 325 images per condition. A T1-weighted scan was 231 obtained for anatomical reference (TR = 8.2, TE = 3.8, FA = 8º, FOV 240*188mm, voxel size 1 x 1 x 1, 232 220 slices). 233 2.5 Data Analysis 234 2.5.1 Behavioral data 235 
Demographic and behavioral data were analyzed using Stata 13 (StataCorp, 2013) with regression 236 analyses and chi-square tests. We analyzed group differences in first investment (baseline trust), 237 and the development of investments (changes in trust) across repeated interactions (indicated by 238 trial number) in each game (cooperative and unfair). We used multilevel random regression 239 analyses to account for multiple observations [investments (level 1); within participants (level 2)]. 240 All analyses were controlled for age and WAIS score. 241 
2.5.2 Imaging data 242 Imaging data were analyzed using Statistical Parametric Mapping 8 (SPM, 2009). Functional images 243 for each participant were preprocessed as follows: realign and unwarp, coregistration with 244 individual structural images, segmented for normalization to an MNI template and smoothing with 245 a 6 mm Gaussian kernel (FWHM). At fist-level, a general linear model was used to construct 246 




individual time courses for the investment and repayment phase per condition, using an event-247 related design. For each trial we defined the investment as the period of stimulus onset to the 248 moment of investment, and the repayment phase as the period during which the partner’s return 249 was displayed (Figure 1). Trials from both the cooperative and unfair conditions were contrasted 250 with control trials. Additionally, cooperative trials were contrasted with unfair trials, to directly 251 compare the differences in response to cooperative and unfair feedback.  252 A priori ROI analyses were performed. ROIs were derived from Gromann et al (2014). 253 Talairach coordinates were converted to MNI space (tal2mni under MatLab), resulting in the 254 following ROIs: right caudate (MNI coordinates 16, 17, 7), superior temporal sulcus (STS; 62, -58, 5) 255 and TPJ (51, -57, 26), left insula (-33, 14, 0), and medial prefrontal cortex (mPFC; -3, 65, 25). We 256 tested group differences using MarsBaR (version0.43; http://marsbar.sourceforge.net). An adjusted 257 
p-value was calculated, taking the correlation between the β-values into account by using the 258 Simple Interactive Statistical Analysis Bonferroni tool 259 (http://www.quantitativeskills.com/sisa/calculations/bonfer.htm), resulting in adjusted p-values 260 (see Table 2) (Li et al, 2014; Woudstra et al, 2013). Additional whole-brain analyses were 261 performed, to investigate activation outside the predefined ROIs.  262 
2.5.3 Associations with symptoms 263 
Group differences in the association of first investment and development of investments with 264 symptoms (paranoia item, positive and negative PANSS subscales) were investigated. The 265 persecution item (P6) and the depression item (G6) were used as an additional index for paranoid 266 ideation, as previously reported (Gromann et al, 2013), and depression, based on CHR comorbidity. 267 Second, beta weights of the ROIs (average over all voxels) were associated with symptoms. To 268 further explore the association of symptoms with behavior and brain activation, additional post-hoc 269 analyses within patient groups were performed. 270 




3 Results 271 
3.1 Participant characteristics  272 Participant characteristics and baseline trust are displayed in Table 1. CHR were significantly older 273 than controls (β = .40, p < .001) and FEP (β = .57, p < .001), and FEP scored significantly lower on 274 the WAIS vocabulary scale than controls (β = -.39, p = .003) and CHR (β = -.31, p = .01). The time 275 between diagnosis and inclusion in the study did not differ significantly between FEP and CHR (β = 276 -.35, p = .21). 277 3.2 Behavioral results 278 Based on the group differences, all analyses were controlled for age and WAIS vocabulary score. 279 Four controls, three FEP and one CHR did not believe they played against a human counterpart. 280 Analyses without these subjects yielded similar results. Below the results of the complete sample 281 are reported. 282 Group differences in baseline trust – the first investment of the first game - were found (β = 283 -.27, p = .02; Table 1), with FEP and CHR showing lower baseline trust than controls (FEP: β = -0.24, 284 
p = .04; CHR: β = -0.25, p < .05). CHR and FEP did not differ significantly from each other (p = 0.8). 285 To investigate the development of trust over trials we performed a three-way interaction 286 “trial number-by-group-by-condition” on investment. This interaction was not significant and 287 therefore removed from the model. Significant trial number-by-group, condition-by-group and trial 288 number-by-condition interactions on investment were found (b = .03, 95% CI [.031, .05], p = .001; b 289 = .49, 95% CI [.28, .71], p < .001; b = -.20, 95% CI [-.24, -.17], p < .001, respectively), indicating that 290 the development of trust differed between groups (Figure 2).  291 In the cooperative condition there was a significant group-by trial number interaction on 292 investment (b = .03, 95% CI [.006, .05], p = .01), with FEP showing significantly stronger increase 293 than controls (b = .08, 95% CI [-.07, .08], p = .03). Controls and CHR did not differ significantly from 294 each other (p = .9). Analysis by group showed that all groups increased investments significantly 295 




(all p’s <.01; see Figure 2a). In the unfair condition, analysis revealed a significant group-by trial 296 number interaction on investment (b = .03, 95% CI [.01, .06], p = .005), with FEP showing 297 significantly less decrease than the other groups (b = -.97, 95% CI [-1.89, -.06], p = .04). All groups 298 decreased investments significantly  (all p’s <.001; see Figure 2b).  299 All analyses were also conducted with medication type (no medication; atypical anti-300 psychotics; combination of typical and atypical; other psychotropic medication) as a grouping 301 variable. No differences in baseline trust, nor in adjustment of trust were found between the 302 medication groups, and no interactions with symptoms on trust were found. 303   304 3.3 Imaging results 305 
ROI analyses revealed significant group differences in the right TPJ only, showing more 306 activation in CHR compared to controls and FEP during the investment phase in the unfair 307 condition (Table 2). Furthermore, CHR activated the TPJ and mPFC more than controls, when 308 investing in an unfair partner compared to a cooperative partner. Other ROIs showed no group 309 differences. During cooperative investment, cooperative and unfair repayment no significant group 310 differences in ROI activation were found. All ROI analyses were also conducted between medication 311 groups. No significant differences in activation were found. 312 Additional exploratory whole-brain analyses, based on a significance level of p < .05 FWE 313 cluster corrected, did not reveal significant group differences. Results with a more lenient threshold 314 are presented in Supplementary Table S1. 315 3.4 Symptoms 316 CHR and FEP did not differ significantly from each other in terms of overall and positive symptoms, 317 and on the depression item. Only on the paranoia item, CHR scored significantly higher than FEP (β 318 = .37, p = .03). There was a trend towards significance indicating that FEP had higher negative 319 symptoms than CHR (p < .07). 320 




3.4.1 Associations between behavioral outcomes and symptoms 321 
No group-by-symptoms interactions on first investment were found (all ps > .24). After removing 322 the interaction from the model, no main effects of symptoms on baseline trust were found (all ps > 323 .16). 324 In the cooperative condition, the group-by-trial number-by-symptoms models showed a 325 significant interaction for negative symptoms only (b = -.02, 95% CI [-.03, -.001], p = .03), indicating 326 that negative symptoms impacted upon the development of trust differentially in the three groups. 327 Post-hoc analyses showed a significant association between symptoms and changes in investments 328 over trials in FEP (b = -.01, 95% CI [-.02, -.003], p = .004), but not in CHR. To visualize this 329 association, we divided the negative symptoms in three levels (Figure 3). Analysis indicated that the 330 only highest level of negative symptoms interfered with increasing investments. No significant 331 interactions with positive symptoms, paranoia, or depression were found. 332 
In the unfair condition the group-by-trial number-by-symptoms models did not show 333 significant interactions. After removing the 3-way interaction from the model, the interaction of 334 positive symptoms with trial number became significant (b = .01, 95% CI [.0002, .012], p = .04). 335 Higher positive symptoms were associated with less decrease in investments in FEP and CHR. 336 Associations of decreasing investment with negative symptoms, paranoia, and depression showed 337 no significant group differences. Analyses within each patient group revealed a significant 338 association between depression and investment over trials in FEP (b = .03, 95% CI [.007, .056], p = 339 .01), showing that FEP with a more severe depression score adjusted their investment less to the 340 negative feedback than FEP with milder depression scores.  341 
3.4.2 Associations of ROI beta weights and symptoms 342 




Beta weights of the ROIs showing group differences (Table 2) were correlated with the positive and 343 negative subscales, and PANSS paranoia and depression score. No group differences were found in 344 the association between symptoms and ROI activation. After removing the group-by-symptoms 345 interaction from the model there was a positive association at trend level for TPJ activation and 346 paranoia in the unfair investment phase (β = .32, p = .07), indicating that in both patient groups the 347 TPJ was increasingly activated in patients with higher paranoia. 348 
Beta weights of the TPJ were unevenly distributed. Therefore, Spearman rank correlation 349 was used for the exploratory analyses per group. This analysis revealed significant associations 350 between symptoms and beta weights of the TPJ for CHR, but not for FEP. Specifically, CHR showed a 351 significant positive association between the paranoia item, positive, and negative symptoms, and 352 TPJ activation during unfair investments (ρ = .57, p = .04; ρ = .70, p = .008; ρ = .64, p = .02, 353 respectively). No associations between symptoms and mPFC activation were found. 354 
 355 
4 Discussion 356 
This study investigated the behavioral and neural mechanisms associated with trust and the 357 association with symptoms in a high-risk (CHR) and first episode psychosis (FEP) sample using an 358 interactive trust game. Participants played two trust games, with a cooperative and an unfair pre-359 programmed partner. Behaviorally, FEP and CHR only differed from controls, and not from each 360 other, showing reduced basic trust, that is initial trust before partner feedback is revealed. No 361 impairments in the development of trust in response to feedback over trials were found in either 362 patient group, compared to controls. Only in FEP associations between trust development and 363 symptoms were found. On the neural level, CHR recruited the TPJ more than the other groups 364 




during investment in the unfair condition, suggesting differential processing as compared to 365 healthy controls and FEP.  366 
4.1 Behavioral mechanisms of trust 367 
Importantly, and in line with previous research both FEP and CHR showed reduced baseline trust 368 toward unknown others (Fett et al, 2015; Fett et al, 2016; Fett et al, 2012; Gromann et al, 2013). 369 Reduced baseline trust has been found in individuals at genetic risk for psychosis, (Fett et al, 2012), 370 but contradicted by another (Gromann et al, 2014). Contrary to previous research (Fett et al, 2016; 371 Fett et al, 2012) baseline trust in FEP and CHR was not associated with symptom severity. The 372 association with positive symptoms found by Fett et al (2012) was at trend level (.09), providing 373 only tentative support. The fact that reduced baseline trust has also been found in individuals at 374 genetic risk for psychosis and now in CHR in combination with the lack of an association with 375 symptoms, tentatively suggests that reduced baseline trust is linked to the risk for psychosis trait, 376 rather than a consequence of the illness (a state marker) that would be associated with (temporal 377 fluctuations of) symptoms. 378 
Feedback learning in cooperative and unfair interactions is still intact in CHR and FEP, as 379 opposed to chronic psychosis (Campellone et al, 2016; Fett et al, 2015). The development of trust in 380 response to positive feedback by the game partner showed, as predicted, that FEP and CHR 381 increased their levels of trust significantly. The same pattern was found in response to negative 382 feedback: over game rounds FEP and CHR decreased their trust to the same level as controls. FEP 383 showed steeper increase in positive interactions than controls, possibly because they were more 384 sensitive to the effects of the positive feedback given they initially had lower expectations, as 385 reflected in lower baseline trust. Furthermore, a ceiling effect might result in a less steep increase 386 for controls, with 23% of the control participants investing the maximum of 10 in 75% or more of 387 




the trials. The slightly reduced response to negative feedback in FEP, resembling results of Fett et al 388 (2016), might be explained by the differences in first investment (FEP starting significantly lower).  389 
4.1.1 Symptoms 390 
Symptom severity on average was similar in the two patient groups. FEP showed substantial 391 variability in symptom severity, which reflects the fact that we included both hospitalized patients 392 and ambulant patients who were in a rehabilitation trajectory. CHR experienced more paranoia 393 than FEP, and FEP tended to have more negative symptoms than CHR. These differences might be 394 explained by medication effects: 64% of the FEP were on atypical antipsychotic medication, 395 probably dampening positive symptoms, whereas 47% of the CHR was on other psychotropic 396 medication (see Table 1). First episode patients with highest negative symptoms, as opposed to 397 milder symptoms, showed almost no adjustment of trust in response to positive feedback. Intact 398 feedback learning mechanisms in FEP were associated with milder negative symptom severity. The 399 association between negative symptoms and problems in social functioning and responding to 400 feedback has been well established in psychosis (Addington & Addington, 2005; Campellone et al, 401 2016; Milev et al, 2005; Strauss et al, 2013; Voges & Addington, 2005; Waltz et al, 2011), possibly 402 reflecting a lack of (social) motivation or depression. In the unfair condition positive symptoms 403 were associated with less decrease in trust in both FEP and CHR. This suggests that positive 404 symptoms interfere with learning from negative social feedback, contradicting earlier findings that 405 found no associations of positive symptoms with learning to trust (Fett et al, 2016).  406 
4.2 Neural mechanisms of trust 407 
On the neural level CHR activated the TPJ significantly more than the other two groups. The TPJ 408 forms part of the mentalizing system (Fletcher et al, 1995; Frith & Frith, 2006; Van Overwalle, 409 2009), and was previously found to be activated in the trust game (King-Casas et al, 2005; Krueger 410 




et al, 2007; Saxe & Kanwisher, 2003; van den Bos et al, 2011). In chronic patients reduced TPJ 411 activation was associated with more positive symptoms (Gromann et al, 2013). In our sample, TPJ 412 activation did not differ between FEP and controls, suggesting a decline in TPJ response with longer 413 illness duration. CHR however, showed increased activation in this area compared to FEP and 414 controls during unfair investment. CHR also showed more TPJ and mPFC activation than controls 415 during investments towards the unfair counterpart, as compared to cooperative counterpart. Since 416 both areas form part of the mentalizing system, this could suggest that unfair interactions elicit 417 increased mentalizing in CHR. Gromann et al (2013), in contrast, found the mPFC to be activated 418 more in cooperative interactions in both patients and controls. Increased neural activation in 419 patients at-risk for psychosis during mentalizing and emotion processing areas despite similar 420 behavioral performance was previously found (Brüne et al, 2011; Derntl et al, 2015; Marjoram et al, 421 2006). The elevated TPJ activation in CHR was associated with higher symptoms in all domains, 422 thus associating higher illness severity with greater neural activity. This association was not found 423 in FEP, possibly suggesting different underlying mechanisms between groups. In combination with 424 the behavioral data, showing that CHR adapted adequately to negative social feedback, the 425 increased TPJ activity could indicate a cognitive mechanism by which increased mentalizing helps 426 to respond adequately to negative feedback, indicating more effort, or an inefficient use of the TPJ. 427 The data do not point to compensating mechanisms, since they would suggest deficiencies or 428 reduced processing in other parts of the brain. These were not found in the ROI analyses, nor in the 429 additional whole brain analyses (see supplementary Table S1). The results show no evidence for 430 reduced sensitivity to social reward in FEP and CHR, and suggest that altered mentalizing might be 431 associated with reduced baseline trust. However, due to the small sample size, this result must be 432 interpreted with caution.  433 
4.3 Clinical high-risk  434 




Following the procedure of previous CHR investigations (Fusar-Poli et al, 2010a; McGorry & 435 van Os, 2013; Phillips et al, 2009; Rietdijk et al, 2012; Shim et al, 2008; Thompson et al, 2012; 436 Valmaggia et al, 2013; van der Gaag et al, 2012; Wood et al, 2011), we included participants 437 assessed with the CAARMS, and with a score below 55 on the SOFAS. Our sample was comparable 438 to other samples in terms of comorbidities (Corcoran et al, 2011; Fusar-Poli et al, 2014; Ising et al, 439 2016; Modinos et al, 2014; Morrison et al, 2012; Woods et al, 2009). One year after testing, e.g. 440 around two years after initial assessment, CHR participants were re-assessed with the CAARMS, to 441 investigate their current status. One of the CHR had made the transition to psychosis. Of two CHR 442 transition data were missing. In this aspect, our high-risk group differed from other high-risk 443 groups. Variant transition rates have been reported in comparable samples with regard to 444 assessment and age range (Broome et al, 2012; Broome et al, 2005; Demjaha et al, 2010; Fusar-Poli 445 et al, 2010b; Nelson et al, 2011). Transition rates in similar referred samples are under 10% 446 (Rietdijk et al, 2012; Yung et al, 2011). Patients already received treatment for their primary 447 problems, including cognitive behavioral therapy (CBT) for their CHR status (psychotic symptoms). 448 This has shown to be an adequate strategy to reduce symptoms, increasing their social functioning 449 skills, to reduce the transition rates (by 46%), and to increase chances for remission (Cannon et al, 450 2008; Ising et al, 2016; Jang et al, 2011; Niendam et al, 2007; van Os & Murray, 2013). 451 In a recent discussion on CHR it has been argued that the presence of psychotic symptoms is 452 possibly more important than transition in the assessment of CHR (van Os & Reininghaus, 2016).  453 Many patients in care for anxiety and depression report psychotic symptoms (van Os & Linscott, 454 2012; van Os & Reininghaus, 2016; Velthorst et al, 2009; Wigman et al, 2012; Woods et al, 2009), 455 but do not transition to psychosis. The current sample fits previous descriptions, making it a 456 representative sample of patients with psychotic symptoms and generally poor mental health. The 457 addition of psychotic symptoms renders these patients at-risk for developing psychopathology, 458 without the direct consequence of developing a psychotic disorder (Fusar-Poli et al, 2013; Yung et 459 




al, 2012). In many cases subclinical psychotic experiences are transitory (van Os & Reininghaus, 460 2016). However, the presence of psychotic symptoms is associated with a poorer prognosis, 461 showing that these patients are certainly in need of special care (McGorry & van Os, 2013; 462 Ruhrmann et al, 2010; Valmaggia et al, 2013; van Os & Linscott, 2012; van Os & Reininghaus, 2016).  463 
4.4 Limitations and future directions 464 
Several limitations should be considered. First, current results should be interpreted with caution, 465 due to the small sample size, especially of the CHR sample. Our CHR results should therefore be 466 considered as a first step in research on real-time social interaction in high-risk individuals, that 467 warrants replication and extension in future research (see also (Broome et al, 2010; Fusar-Poli et 468 al, 2011; Juckel et al, 2012). With a larger CHR sample, the number of converters will increase, 469 allowing for an investigation of converters vs. non-converters. Additionally, a larger sample would 470 provide the possibility to subdivide the CHR sample on the basis of different symptomatology 471 (Fusar-Poli et al, 2014; Valmaggia et al, 2013), yielding more insight in the factors causing social 472 problems, and explaining transition trajectories. Transition in these studies was not explained by 473 comorbid anxiety and depression, but by the severity of CAARMS score, social dysfunction and 474 increased negative symptoms. Direct comparison between at-risk subjects with and without 475 progression into a diagnosis of schizophrenia could also elucidate whether greater activation of the 476 mentalizing network in CHR is serving as a compensatory mechanism, or could also be linked to 477 transition to psychosis. Larger samples could have revealed group differences that were not 478 apparent in this sample. Further, FEP symptom severity was rather mild, possibly due to 479 responsiveness to antipsychotic treatment. Similar symptom severity has been found in stable and 480 medicated patients (Möller et al, 2005). Including a broader range of symptom severity would 481 increase the validity of the sample. Methodologically, a limitation is that participants were not paid 482 on performance. There is some evidence that real payment has a different effect on decisions and 483 




related brain activity than hypothetical payment (Hertwig & Ortmann, 2001; Johnson & Mislin, 484 2011; Vlaev, 2012), but other studies have found no differences (Locey et al, 2011; Madden et al, 485 2003). Plausibly, hypothetical payment may influence the strength, but not the direction of the 486 effect (Derks, 2015). Furthermore, eight participants did not believe they were playing against a 487 human counterpart. This might have influenced their behavior. However, analyses without these 488 participants did not change the results. Adequate increase and decrease of investments in response 489 to cooperative and unfair feedback showed that overall the experimental manipulation of the 490 counterpart was effective. Additionally, including an online mentalizing task in the scanner could 491 establish direct links with the current outcomes, pointing in the direction of differential mentalizing 492 processes. 493 
 494 
5 Conclusion 495 
Summarizing, baseline trust is impaired in FEP and CHR, indicating that reduced baseline 496 trust is associated with the risk for psychotic illness trait, or with poor mental health in general, 497 rather than a consequence of psychotic disorder. CHR performed in between controls and FEP 498 (Pukrop et al, 2006; Thompson et al, 2012), resembling most the patient group. In contrast to 499 chronic patients (Fett et al, 2015), reward learning was not impaired in FEP and CHR (see also 500 (Juckel et al, 2012). This suggests that with positive social feedback, the lack of initial trust in FEP 501 and CHR can be restored, at least in the context of the trust game. The neural results pointed to 502 globally intact neural mechanisms associated with trust, except for changes in brain areas 503 associated with mentalizing in CHR. However, these findings should be considered as preliminary, 504 and more research in the field is needed to replicate and extend our findings. 505 
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Table 1 774 




 780  781  782  783  784  785  786  787 
 788  789  790  791  792  793 * = significant difference between FEP and CHR at p < .05  794 ** = significantly different from both other groups at p < .05 795 *^ = FEP > CHR at p < .07 796 
Note: CHR = clinical high-risk; FEP = first episode psychosis; SD = standard deviation; WAIS = 797 Wechsler Adult Intelligence Scale; PANSS = Positive and Negative Syndrome Scale; SSRI = selective 798 serotonin reuptake inhibitors. The paranoia item forms part of the positive subscale (P6), the 799 
 Controls 
N = 43 CHR N = 17 FEP N = 22 Gender, N male (%) 22 (51.16 %) 7 (41.18 %) 14 (63.64 %) Age, mean (SD) 21.06 (2.74) 23.78 (2.42) ** 19.88 (1.54) WAIS vocabulary, mean (SD) 41.77 (11.39) 41.71 (12.16) 32.5 (10.53) ** PANSS                 total (SD) mean (SD)  58.92 (11.84) 1.95 (.37) 61.32 (14.51) 2.09 (.51) - Positive      total (SD) mean (SD)  13.38 (2.59) 1.91 (.39) 13.23 (5.72) 1.89 (.82) - Negative    total (SD) mean (SD)  13.69 (3.73) 1.96 (.53) 17.18 (5.85) 2.45 (.84)*^ - General      total (SD)  mean (SD)  31.85 (6.07) 2.0 (.38) 30.91 (7.66) 1.93 (.48) - Paranoia    mean (SD)  3.38 (1.50) 2.23 (1.41)* - Depression mean (SD)  4 (1.73) 2.89 (1.49)_ Medicated N (%)  8 (47%)* 16 (73%) - Atypical anti-psychotics (%)   13 (81.5%) - Typical and atypical antipsychotics (%)  1 (6.25%) - Anti-depressant (%)  3 (37.5%) - - SSRI (%)  3 (37.5%) - - Benzodiazepine (%)  2 (25%) 1 (6.25%) - Sertraline (%)  - 1 (6.25%) Baseline trust, mean (SD) 7.02 (1.81)** 5.82 (2.32) 5.52 (2.02) 




depression item forms part of the general subscale (G6). For analyses, these item were investigated 800 separately. 801 
802 




Table 2 803 Region of Interest (ROI) Analyses Outcome 804 Condition  ROI p Contrast  Location  Unfair Investment *      TPJ TPJ .019 <.001 CHR > FEP CHR > Controls     TPJ Unfair investment > cooperative investment **    TPJ mPFC .005 .007 CHR > Controls  CHR > Controls     mPFC 
Note: * = adjusted significance level for multiple comparisons of p = .027.  805 ** = adjusted significance level of p = .012.  806 Montreal Neurological Institute (MNI) coordinates: TPJ = temporo-parietal junction, 51, -57, 26; 807 mPFC = medial prefrontal cortex, -3, 65, 25. CHR = clinical high-risk; FEP = first episode psychosis 808 
  809  810 
